151 – 160 of 1023
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy
- Contribution to journal › Scientific review
-
Mark
Comprehending the proteomic landscape of ovarian cancer : A road to the discovery of disease biomarkers
- Contribution to journal › Scientific review
-
Mark
Potential immunoregulatory role of T and dendritic cells in cancer : Investigations based on transcriptional analysis
(2021)
- Thesis › Doctoral thesis (compilation)
-
Mark
The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo
- Contribution to journal › Article
-
Mark
Psychological resilience and health‐related quality of life in 418 swedish women with primary breast cancer : Results from a prospective longitudinal study
- Contribution to journal › Article
-
Mark
Identification of a serum biomarker signature associated with metastatic prostate cancer
- Contribution to journal › Article
-
Mark
Poorly Expressed Alleles of Several Human Immunoglobulin Heavy Chain Variable Genes are Common in the Human Population
- Contribution to journal › Article
-
Mark
Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
- Contribution to journal › Article
-
Mark
Large Extracellular Vesicle Characterization and Association with Circulating Tumor Cells in Metastatic Castrate Resistant Prostate Cancer
- Contribution to journal › Article
-
Mark
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
- Contribution to journal › Article
